Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

XLRN

Acceleron Pharma (XLRN)

Acceleron Pharma Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:XLRN
FechaHoraFuenteTítuloSímboloCompañía
02/04/201409:54Dow Jones NewsCelgene Agrees to Acquire 1.1 Million Acceleron Pharma SharesNASDAQ:XLRNAcceleron Pharma Inc
02/04/201406:58Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:XLRNAcceleron Pharma Inc
24/03/201406:30Business WireAcceleron, Celgene & Collaborators Announce Two Publications in Nature Medicine Describing Sotatercept & ACE-536 Therapeutic ...NASDAQ:XLRNAcceleron Pharma Inc
21/03/201407:00PR Newswire (US)Earnings Release and Presentation Schedules, Nominations, and Financial Results - Analyst Notes on Five Prime Therapeutics, A...NASDAQ:XLRNAcceleron Pharma Inc
20/03/201406:30Business WireAcceleron to Present at the 21st Annual Future Leaders in the Biotech Industry ConferenceNASDAQ:XLRNAcceleron Pharma Inc
17/03/201416:27Edgar (US Regulatory)Annual Report (10-k)NASDAQ:XLRNAcceleron Pharma Inc
17/03/201415:30Business WireAcceleron & Celgene Announce Interim Clinical Data for Sotatercept in Patients with End Stage Renal Disease on Hemodialysis a...NASDAQ:XLRNAcceleron Pharma Inc
07/03/201405:19PR Newswire (US)Financial Results Releases, Clinical Study Updates, Stock Summaries, and Strategic Agreements - Analyst Notes on Insmed, Medt...NASDAQ:XLRNAcceleron Pharma Inc
27/02/201406:00Business WireAcceleron to Present at Cowen and Company 34th Annual Health Care ConferenceNASDAQ:XLRNAcceleron Pharma Inc
26/02/201406:00Business WireAcceleron Pharma Reports Fourth Quarter and Year Ended 2013 Financial ResultsNASDAQ:XLRNAcceleron Pharma Inc
19/02/201406:00Business WireAcceleron Pharma to Host Fourth Quarter and Year Ended 2013 Financial Results Conference Call and Webcast on February 26, 2014NASDAQ:XLRNAcceleron Pharma Inc
14/02/201415:35Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:XLRNAcceleron Pharma Inc
14/02/201412:47Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:XLRNAcceleron Pharma Inc
05/02/201406:00Business WireAcceleron to Present at 2014 Leerink Global Healthcare ConferenceNASDAQ:XLRNAcceleron Pharma Inc
30/01/201415:05Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:XLRNAcceleron Pharma Inc
28/01/201415:30Business WireAcceleron Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:XLRNAcceleron Pharma Inc
22/01/201421:30Business WireAcceleron Announces Pricing of Public Offering of Common StockNASDAQ:XLRNAcceleron Pharma Inc
21/01/201405:30Business WireAcceleron Commences Proposed Public Offering of Common StockNASDAQ:XLRNAcceleron Pharma Inc
16/01/201417:50ZacksPipeline Update from XenoPort - Analyst BlogNASDAQ:XLRNAcceleron Pharma Inc
14/01/201417:50ZacksPipeline Update from BioDelivery Sciences - Analyst BlogNASDAQ:XLRNAcceleron Pharma Inc
09/01/201417:09Business WireAcceleron Files Registration Statement for Proposed Public Offering of Common StockNASDAQ:XLRNAcceleron Pharma Inc
20/12/201306:00Business WireAcceleron Pharma to Be Added to Russell 2000® IndexNASDAQ:XLRNAcceleron Pharma Inc
18/12/201306:00Business WireAcceleron Earns $7 Million Milestone Payment for Celgene’s Initiation of Sotatercept Phase 2 Clinical Trial in Patients wit...NASDAQ:XLRNAcceleron Pharma Inc
09/12/201310:00Business WireAcceleron & Celgene Report New Interim Clinical Data from Phase 2 Trial of Sotatercept in Beta-Thalassemia at 2013 American S...NASDAQ:XLRNAcceleron Pharma Inc
03/12/201306:00Business WireAcceleron Pharma Provides Update on Clinical Pipeline at Piper Jaffray Healthcare ConferenceNASDAQ:XLRNAcceleron Pharma Inc
02/12/201306:00Business WireAcceleron Announces New Interim Phase 2 Sotatercept Clinical Data in Beta-Thalassemia to be Presented at 2013 American Societ...NASDAQ:XLRNAcceleron Pharma Inc
25/11/201306:00Business WireAcceleron to Present at Piper Jaffray Healthcare Conference in DecemberNASDAQ:XLRNAcceleron Pharma Inc
06/11/201306:00Business WireAcceleron Pharma Reports Third Quarter 2013 Financial ResultsNASDAQ:XLRNAcceleron Pharma Inc
05/11/201307:15Business WireAcceleron Pharma to Ring The NASDAQ Stock Market Closing Bell on November 5, 2013NASDAQ:XLRNAcceleron Pharma Inc
30/10/201307:00Business WireAcceleron Pharma to Host Third Quarter 2013 Financial Results Conference Call and Webcast on November 6, 2013NASDAQ:XLRNAcceleron Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:XLRN

Su Consulta Reciente

Delayed Upgrade Clock